Current Opinion in Pulmonary Medicine最新文献_第8页

Chronic obstructive pulmonary disease exacerbations for the academic hospitalist: an opportunity to learn and improve care. 慢性阻塞性肺疾病加重的学术医院医生：一个机会，以学习和改善护理。

IF 2.7 3区医学

Current Opinion in Pulmonary Medicine Pub Date : 2026-03-01 Epub Date: 2025-12-29 DOI: 10.1097/MCP.0000000000001242

Sandra Emily Pruitt, T Ples Spradley, Thaddeus Bartter

{"title":"Chronic obstructive pulmonary disease exacerbations for the academic hospitalist: an opportunity to learn and improve care.","authors":"Sandra Emily Pruitt, T Ples Spradley, Thaddeus Bartter","doi":"10.1097/MCP.0000000000001242","DOIUrl":"10.1097/MCP.0000000000001242","url":null,"abstract":"Purpose of review: Hospitalists are at the forefront of managing chronic obstructive pulmonary disease (COPD) exacerbations. While patients may be followed by a pulmonologist outpatient, their care in the hospital is largely managed by internists. Our review addresses critical aspects of COPD care for the patient admitted to the hospital under the care of internal medicine.Recent findings: When patients are hospitalized for COPD, the hospitalist has a critical opportunity to address tobacco cessation, vaccinations, and end-of-life issues. For hospitalists who are in academic medicine, teaching trainees the important mimickers of COPD exacerbations and how to establish the diagnosis are critical for their training. While these patients are hospitalized, ensuring adequate sleep and avoiding unnecessary night-time nebulizer use allows for patient recovery and wellbeing.Summary: COPD exacerbations represent an opportunity for hospitalists to provide high-quality, comprehensive care for the patient and invaluable teaching for the trainee.","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"115-120"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145849141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Strategies to decrease exacerbations of chronic obstructive pulmonary disease: can they impact disease progression? 减少慢性阻塞性肺疾病恶化的策略：它们能影响疾病进展吗？

IF 2.7 3区医学

Current Opinion in Pulmonary Medicine Pub Date : 2026-03-01 Epub Date: 2025-10-29 DOI: 10.1097/MCP.0000000000001231

Umur Hatipoğlu

{"title":"Strategies to decrease exacerbations of chronic obstructive pulmonary disease: can they impact disease progression?","authors":"Umur Hatipoğlu","doi":"10.1097/MCP.0000000000001231","DOIUrl":"10.1097/MCP.0000000000001231","url":null,"abstract":"Purpose of review: Preventing disease progression is a key element of chronic obstructive pulmonary disease (COPD) management. COPD exacerbations are adverse events that can result in a decline of lung function that can persevere. Therefore, reducing exacerbation frequency has the potential to affect disease progression and improve health status of COPD patients. This narrative review explores monitoring for disease progression in COPD and its potential association with COPD exacerbations.Recent findings: Pharmacotherapy can slow down disease progression, but the effect is mediated only in part by reducing exacerbations. While disease progression is continuous, patients with established airflow obstruction in early stages appear more vulnerable to faster declines in lung function. Longitudinal monitoring of lung function and structure is necessary to identify patients with disease progression.Summary: Pharmacotherapy is an effective option for preventing disease progression. A holistic approach including longitudinal pulmonary function testing, clinical symptoms and imaging may be necessary to detect disease progression for early intervention.","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"107-114"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145399967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Lung transplantation for chronic obstructive pulmonary disease patients: an overview. 慢性阻塞性肺疾病患者的肺移植：综述

IF 2.7 3区医学

Current Opinion in Pulmonary Medicine Pub Date : 2026-03-01 Epub Date: 2025-10-08 DOI: 10.1097/MCP.0000000000001226

Talli Ida Naamani, Veronique Verplancke, Geert M Verleden

{"title":"Lung transplantation for chronic obstructive pulmonary disease patients: an overview.","authors":"Talli Ida Naamani, Veronique Verplancke, Geert M Verleden","doi":"10.1097/MCP.0000000000001226","DOIUrl":"10.1097/MCP.0000000000001226","url":null,"abstract":"Purpose of review: To provide an overview of current indications for lung transplantation (LTx) in COPD patients, to describe the different transplantation options, to compare the outcome of COPD and alpha1-antitrypsin deficiency (AATD) patients versus non-AATD COPD patients and to discuss the possible complications, also specifically related to COPD, AATD patients and the transplantation procedure.Recent findings: Some 30-50% of all lung LTx worldwide are performed in COPD patients, with the majority being operated via double lung transplantation (DLTx). Unilateral lung transplantation (SLTx) remains an option, depending on the donor availability and the center's experience. The mean survival after LTx for COPD remains somewhat lower compared to other underlying diseases, especially after SLTx, which may lead to specific complications such as native lung hyperinflation and development of a native lung cancer.Summary: LTx for end-stage COPD remains an accepted treatment modality in selected patients, which increases the QOL and the survival. The global 5-year survival is around 60%; somewhat better for AATD, compared to non-AATD COPD and after DLTx compared to SLTx. The best procedure of choice remains a matter for further discussion, although most centers prefer to perform DLTx, certainly in patients with underlying AATD.","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"129-135"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145250376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Respiratory health issues in indoor water parks: a review of noninfectious and infectious complications. 室内水上乐园的呼吸健康问题：非传染性和传染性并发症的综述

IF 2.7 3区医学

Current Opinion in Pulmonary Medicine Pub Date : 2026-03-01 Epub Date: 2026-01-08 DOI: 10.1097/MCP.0000000000001237

Vaibhav Ahluwalia, Vivek N Iyer

{"title":"Respiratory health issues in indoor water parks: a review of noninfectious and infectious complications.","authors":"Vaibhav Ahluwalia, Vivek N Iyer","doi":"10.1097/MCP.0000000000001237","DOIUrl":"10.1097/MCP.0000000000001237","url":null,"abstract":"Purpose of review: Indoor water parks, with over 1100 facilities in the United States, are popular recreational venues with an estimated 1.5 million visitors per year in North America. While generally well tolerated, they can be associated with significant respiratory and nonrespiratory health risks. This review focuses exclusively on the infectious and noninfectious respiratory health issues associated with indoor water park usage and is timely due to increasing popularity, evolving water-treatment practices, and the unique vulnerability of specific populations.Recent findings: This review synthesizes peer-reviewed studies and institutional data from 2014 to 2024, detailing exposure mechanisms, health effects, mitigation strategies, and impacts on vulnerable populations such as children, asthmatic individuals, cystic fibrosis patients, immunocompromised individuals, and workers. Topics covered include disinfection by-products (DBPs), chloramine inhalation effects, asthma risks, hypersensitivity pneumonitis from nontuberculous mycobacteria, and occupational exposures. Emerging technologies in air and water quality management, alongside recent policy and facility-design developments, are also examined.Summary: While indoor water parks remain a valued recreational resource, they pose significant and often under-recognized respiratory risks. Through better facility ventilation, hygiene education, disinfection innovation, and regulatory reform, these risks can be mitigated to protect both patrons and staff, particularly in vulnerable subpopulations.","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"77-82"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Advanced bronchoscopy therapies for emphysema: current state and future potentials. 先进的支气管镜治疗肺气肿：现状和未来的潜力。

IF 2.7 3区医学

Current Opinion in Pulmonary Medicine Pub Date : 2026-03-01 Epub Date: 2025-11-19 DOI: 10.1097/MCP.0000000000001236

Anand Tana, Pallav L Shah

{"title":"Advanced bronchoscopy therapies for emphysema: current state and future potentials.","authors":"Anand Tana, Pallav L Shah","doi":"10.1097/MCP.0000000000001236","DOIUrl":"10.1097/MCP.0000000000001236","url":null,"abstract":"Purpose of review: Emphysema is a phenotype of chronic obstructive pulmonary disease that is characterized by irreversible parenchyma destruction and loss of elastic recoil, resulting in air trapping and hyperinflation. Despite optimal medical management, many patients remain symptomatic. Bronchoscopic lung volume reduction (BLVR) techniques provide minimally invasive alternatives to surgery. This review summarizes the current role and future directions of advanced bronchoscopic therapies for emphysema.Recent findings: Established BLVR approaches aim to induce atelectasis of diseased, hyperinflated lobes using endobronchial valves or thermal vapor ablation. Patient selection and clinical efficacy is critically influenced by emphysema distribution and the presence of collateral ventilation. To address these limitations, novel therapies are being developed. Sealants are under investigation as adjuncts to valve therapy to overcome collateral ventilation. Endobronchial coils mechanically re-tension the lung parenchyma, improving elastic recoil and airway patency. Airway stents and scaffolds are designed to facilitate expiratory flow by either bypassing or preventing closure of collapsible airways. These emerging modalities may extend treatment options to patients with homogeneous disease and those with significant collateral ventilation, groups traditionally with limited existing interventions.Summary: Current BLVR therapies remain limited in homogeneous disease and collateral ventilation-positive patients. Research into novel treatments have shown promise in an expanding therapeutic landscape, though long-term safety, durability, and patient selection criteria require further study.","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":"32 2","pages":"121-128"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148148721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Impact of e-cigarettes and flavoured vapes on respiratory health: where are we now? 电子烟和调味电子烟对呼吸系统健康的影响：我们现在在哪里？

IF 2.7 3区医学

Current Opinion in Pulmonary Medicine Pub Date : 2026-03-01 Epub Date: 2025-12-17 DOI: 10.1097/MCP.0000000000001241

Maja Omcikus, Donald P Tashkin, Sanja Dimic-Janjic, Igor Barjaktarevic

{"title":"Impact of e-cigarettes and flavoured vapes on respiratory health: where are we now?","authors":"Maja Omcikus, Donald P Tashkin, Sanja Dimic-Janjic, Igor Barjaktarevic","doi":"10.1097/MCP.0000000000001241","DOIUrl":"10.1097/MCP.0000000000001241","url":null,"abstract":"Purpose of review: The use of electronic cigarettes (e-cigarettes) for delivering nicotine has increased markedly in recent years, raising concerns regarding their long-term safety and their potential to sustain nicotine dependence, particularly among adolescents and young adults. Marketed as safer alternatives to conventional cigarettes, e-cigarettes warrant careful evaluation of both their short-term and long-term health risks.Recent findings: Evidence from systematic reviews suggests that e-cigarettes may serve as a tool for smoking reduction or cessation; however, available data indicate that usage often represents product switching rather than complete cessation. Given that e-cigarettes are not harmless, the advisability of recommending them as a smoking cessation aid remains controversial. Although long-term outcomes are not fully established, current research suggests that e-cigarettes could be responsible for acute lung injury, exacerbations of respiratory symptoms, chronic obstructive pulmonary disease progression, and various pathophysiological changes associated with cytotoxicity and airway dysfunction.Summary: Considering the accumulating evidence of harm, e-cigarettes should be regulated similarly to conventional tobacco products, with strict restrictions on access for children and adolescents. Further longitudinal studies are needed to clarify their long-term health effects and to guide evidence-based public health policies.","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"83-92"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145766912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Update on linear endobronchial ultrasound. 线性支气管超声的最新进展。

IF 2.7 3区医学

Current Opinion in Pulmonary Medicine Pub Date : 2026-01-01 Epub Date: 2025-11-19 DOI: 10.1097/MCP.0000000000001227

Nobuyasu Awano, Takehiro Izumo, Takahiro Nakajima

{"title":"Update on linear endobronchial ultrasound.","authors":"Nobuyasu Awano, Takehiro Izumo, Takahiro Nakajima","doi":"10.1097/MCP.0000000000001227","DOIUrl":"10.1097/MCP.0000000000001227","url":null,"abstract":"Purpose of review: Linear endobronchial ultrasound (EBUS) plays a central role in the diagnosis and mediastinal staging of lung cancer. Recent advancements, including the 9th edition of the International Association for the Study of Lung Cancer (IASLC) TNM staging system and updated guidelines for neoadjuvant therapy, have significantly influenced its clinical utility. This review highlights these key developments and examines the expanding role of EBUS-guided tissue acquisition techniques and rapid on-site evaluation (ROSE).Recent findings: The IASLC 9th edition offers a more nuanced nodal classification, reinforcing the importance of accurate EBUS-guided lymph node assessment. As neoadjuvant therapies become more common, precise pretreatment staging is critical for treatment planning. Emerging biopsy techniques, such as EBUS-guided intranodal forceps biopsy and cryobiopsy, yield larger tissue samples, improving diagnostic accuracy in complex cases, including lymphoma and benign diseases. Additionally, the integration of artificial intelligence into ROSE enhances the real-time diagnostic performance and mitigates the limitations of traditional cytopathology.Summary: EBUS has evolved from diagnostic modality to a cornerstone of personalized lung cancer management. A clear understanding of updated staging systems, therapeutic guidelines, and biopsy strategies is essential. Future research should aim to establish evidence-based diagnostic algorithms incorporating these innovations to optimize patient care.","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"38-45"},"PeriodicalIF":2.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145556502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Intraprocedural real-time imaging and tissue sampling in peripheral bronchoscopy. 外周支气管镜术中实时成像和组织采样。

IF 2.7 3区医学

Current Opinion in Pulmonary Medicine Pub Date : 2026-01-01 Epub Date: 2025-10-28 DOI: 10.1097/MCP.0000000000001222

Grant Senyei, Brian D Shaller, Christopher Di Felice, Sonali Sethi

{"title":"Intraprocedural real-time imaging and tissue sampling in peripheral bronchoscopy.","authors":"Grant Senyei, Brian D Shaller, Christopher Di Felice, Sonali Sethi","doi":"10.1097/MCP.0000000000001222","DOIUrl":"10.1097/MCP.0000000000001222","url":null,"abstract":"Purpose of review: Peripheral lung lesions remain a prevalent and diagnostically challenging clinical entity. While computed tomography (CT)-guided transthoracic needle aspiration has been the gold-standard for tissue diagnosis, recent advances in technology have led to an increase in the ability of navigational bronchoscopy to successfully reach these lesions.However, despite successful bronchoscopic navigation based on preprocedural CT, diagnostic yield remains low if the proceduralist is unable to identify and correct CT-to-body divergence or confirm tool-in-lesion while sampling the lesion.The use of improved intraprocedural imaging techniques and biopsy tools have provided new techniques to correct positioning and sample lesions with greater diagnostic yield.Recent findings: Integration of axial imaging in the form of fixed and mobile cone beam CT, digital tomosynthesis, and augmented fluoroscopy into bronchoscopic procedures have led to improved diagnostic accuracy. These advances improve peripheral bronchoscopy through identification and compensation of navigational errors relative to changes in real-time lesion location and confirmation of biopsy instrument location within the lesion.Summary: Real-time imaging that is capable of identifying and correcting for CT-to-body divergence is vital to the increased diagnostic accuracy of peripheral bronchoscopic procedures.","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"23-31"},"PeriodicalIF":2.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145250359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Diagnostic yield: what is sufficient? 诊断产率：多少才足够？

IF 2.7 3区医学

Current Opinion in Pulmonary Medicine Pub Date : 2026-01-01 Epub Date: 2025-11-11 DOI: 10.1097/MCP.0000000000001232

Yuji Matsumoto, Anne V Gonzalez

{"title":"Diagnostic yield: what is sufficient?","authors":"Yuji Matsumoto, Anne V Gonzalez","doi":"10.1097/MCP.0000000000001232","DOIUrl":"10.1097/MCP.0000000000001232","url":null,"abstract":"Purpose of review: Advances in diagnostic bronchoscopy seek to optimize diagnostic yield while maintaining the safety profile of conventional bronchoscopy. Despite rapid technological progress, inconsistent outcome definitions have hindered pooling of data across studies and comparisons across technologies. This review aims to clarify how a standardized definition of diagnostic yield can enhance comparability and clinical interpretation in advanced diagnostic bronchoscopy.Recent findings: The recent ATS/CHEST consensus statement provides a rigorous framework for defining and reporting diagnostic yield, enabling meaningful cross-study comparisons. Beyond definitions of diagnostic outcome measures, optimization of tissue acquisition and processing through close collaboration between bronchoscopists and pathologists is critical. Current evidence supports the use of coordinated sampling strategies to secure sufficient, high-quality material for molecular testing, particularly for large-panel next-generation sequencing (NGS). Advances in EBUS-TBNA, cryobiopsy, and robotic bronchoscopy have improved sample yield and quality for genomic profiling. In parallel, liquid biopsy using circulating tumor DNA provides a minimally invasive adjunct, particularly valuable when tissue is limited, exhausted, or longitudinal monitoring is required; however, its sensitivity remains constrained in low-shedding diseases.Summary: Adherence to a strict definition of diagnostic yield, combined with optimized sampling and integrated molecular testing, ensures that technological innovation in bronchoscopy translates into clinically meaningful, precise, and patient-centered diagnosis of lung cancer.","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"46-53"},"PeriodicalIF":2.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145494336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Foreign body removal. 异物清除。

IF 2.7 3区医学

Current Opinion in Pulmonary Medicine Pub Date : 2026-01-01 Epub Date: 2025-10-10 DOI: 10.1097/MCP.0000000000001225

Rajiv Goyal, Inderpaul Singh Sehgal, Ritesh Agarwal

{"title":"Foreign body removal.","authors":"Rajiv Goyal, Inderpaul Singh Sehgal, Ritesh Agarwal","doi":"10.1097/MCP.0000000000001225","DOIUrl":"10.1097/MCP.0000000000001225","url":null,"abstract":"Purpose of review: Airway foreign body aspiration remains a potentially life-threatening emergency, predominantly affecting children under 5 years and adults over 65 years. This review synthesizes current evidence on diagnostic strategies, bronchoscopic extraction techniques, procedural outcomes, complication management, and emerging technologies in airway foreign body management.Recent findings: Multidetector computed tomography with three-dimensional reconstruction has significantly improved diagnostic accuracy, achieving sensitivity of 98-99% for radiopaque objects and 85-92% for radiolucent materials. Flexible bronchoscopy has evolved from a diagnostic tool to a first-line therapeutic modality, with recent pediatric meta-analyses demonstrating 87% success rates and adult series showing comparable outcomes to rigid bronchoscopy for appropriately selected cases. Rigid bronchoscopy maintains superiority in asphyxiating presentations, and for large (>1.5 cm), sharp, or severely impacted foreign bodies. Technological innovations including robotic-assisted bronchoscopy, electromagnetic navigation systems, and artificial intelligence-powered imaging analysis are enhancing procedural precision and safety.Summary: Successful airway foreign body management requires individualized, multidisciplinary approaches integrating patient clinical status, foreign body characteristics, and institutional expertise. Success depends on appropriate bronchoscopic modality selection, comprehensive preprocedural planning, availability of specialized retrieval instruments, and readiness to manage potential complications. Integration of advanced imaging, simulation-based training protocols, and telemedicine consultation are becoming essential components of contemporary practice.","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":" ","pages":"63-73"},"PeriodicalIF":2.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145273944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0